http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6653293-B1
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02A50-30 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-191 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-70 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-18 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-70 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-19 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-00 |
| filingDate | 1993-10-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2003-11-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e6fe6f86a328cdf030f98a1cd586409e http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_542c47bfe9ffc7e63d46b6e039ce7c0d |
| publicationDate | 2003-11-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | US-6653293-B1 |
| titleOfInvention | Methods, apparatuses and medicaments for treating body fluid related diseases |
| abstract | This invention relates to two methods treating such disease as AIDS. The first method includes administering the Trigger Factor such as TNF, which is defined as substance stimulating infected cells to increase HIV replication and hence subjecting the infected cells to death or the programmed death (apoptosis), further administering new-infection suppressor such as AZT and preferably inducer to migrate infected cells (lymphocytes) to the blood system from the lymphatic system, and then continuing extinction of the replicated HIVs by extracorporeal blood processing until all the infected cells die.The second method includes administering electroconductive and/or magnetic microparticles on the surface whereon of which such infectiously adhesive substance to HIVs and infected cells as CD4 is coated, and killing HIVs/infected cells adhered to the microparticles by heating the microparticles with electromagnetic field (wave) applied externally to the patient. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11364330-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2009281473-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2011295175-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11383015-B2 |
| priorityDate | 1992-10-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 43.